CRA is a proud exhibiting sponsor of this event.
Cecile Matthews is presenting during the session titled “What is the relationship between price and prevalence in non-oncology rare disease?”
Greg Bell is presenting during the session titled “Simplifying patient tracking,” showcasing RD Navigator.
For more information on this event, click here.
MFN is rewriting the launch planning playbook: Commercial and market access strategies must integrate to succeed
MFN-related uncertainty is reshaping pharmaceutical launch planning by making pricing, sequencing, and forecasting decisions more interconnected and...